While on this thread:
after re-reading the latest Life Science Leader Magazine interview(earlier post) with Centyrex CEO Robert Hayes and in-particular the following:
"The BCE has also assumed responsibility for Centyrin products already in development"
I'd suggest, any party connected to the Centyrin work would now be dealing with the scientists and decision makers within Janssen R&D Biotechnology Center of Excellence (BCE).
SoT
janssen presentation on centyrins, page-29
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.005(5.00%) |
Mkt cap ! $489.9M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.8¢ | 10.3¢ | $421.2K | 4.009M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 872943 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 341133 | 4 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| PYC (ASX) Chart |